Sam L Barker is Director of LEXICON PHARMACEUTICALS, INC.. Currently has a direct ownership of 124,459 shares of LXRX, which is worth approximately $92,099. The most recent transaction as insider was on May 13, 2025, when has been sold 36,810 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K
42.0% 3M change
42.0% 12M change
Total Value Held $92,099

SAM L BARKER Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 13 2025
BUY
Exercise of conversion of derivative security
-
36,810 Added 22.83%
124,459 Common Stock
Apr 28 2024
BUY
Exercise of conversion of derivative security
-
8,032 Added 8.39%
87,649 Common Stock
May 21 2023
BUY
Exercise of conversion of derivative security
-
9,302 Added 10.46%
79,617 Common Stock
Apr 30 2022
BUY
Exercise of conversion of derivative security
-
4,024 Added 5.41%
70,315 Common Stock
Apr 24 2021
BUY
Exercise of conversion of derivative security
-
10,638 Added 13.83%
66,291 Common Stock

Also insider at

CYCC
Cyclacel Pharmaceuticals, Inc. Healthcare
SLB

Sam L Barker

Director
The Woodlands, TX

Track Institutional and Insider Activities on LXRX

Follow LEXICON PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells LXRX shares.

Notify only if

Insider Trading

Get notified when an Lexicon Pharmaceuticals, Inc. insider buys or sells LXRX shares.

Notify only if

News

Receive news related to LEXICON PHARMACEUTICALS, INC.

Track Activities on LXRX